Conversion of oxacillin-resistant staphylococci from heterotypic to homotypic resistance expression.
about
Heteroresistance to Fosfomycin Is Predominant in Streptococcus pneumoniae and Depends on the murA1 GeneTargeting of PBP1 by β-lactams determines recA/SOS response activation in heterogeneous MRSA clinical strainsExposure of clinical MRSA heterogeneous strains to β-lactams redirects metabolism to optimize energy production through the TCA cycleTCA cycle-mediated generation of ROS is a key mediator for HeR-MRSA survival under β-lactam antibiotic exposureBacterial and host factors implicated in nasal carriage of methicillin-resistant Staphylococcus aureus in mice.A low-affinity penicillin-binding protein 2x variant is required for heteroresistance in Streptococcus pneumoniae.PBP2a mutations causing high-level Ceftaroline resistance in clinical methicillin-resistant Staphylococcus aureus isolates.Cell wall thickening is a common feature of vancomycin resistance in Staphylococcus aureusmecA-blaZ corepressors in clinical Staphylococcus aureus isolatesQuantitation of mecA transcription in oxacillin-resistant Staphylococcus aureus clinical isolatesHeteroresistance to penicillin in Streptococcus pneumoniae.β-Lactams increase the antibacterial activity of daptomycin against clinical methicillin-resistant Staphylococcus aureus strains and prevent selection of daptomycin-resistant derivatives.Spontaneous deletion of the methicillin resistance determinant, mecA, partially compensates for the fitness cost associated with high-level vancomycin resistance in Staphylococcus aureus.Development of homogeneous expression of resistance in methicillin-resistant Staphylococcus aureus clinical strains is functionally associated with a beta-lactam-mediated SOS response.Identification of point mutations in clinical Staphylococcus aureus strains that produce small-colony variants auxotrophic for menadionePenicillin-binding protein 2a of methicillin-resistant Staphylococcus aureus.Restoration of oxacillin susceptibility in methicillin-resistant Staphylococcus aureus by blocking the MecR1-mediated signaling pathway.Antibiotic resistance in Staphylococcus aureus. Current status and future prospects.Genetic alterations responsible for reduced susceptibility to vancomycin in community-associated MRSA strains of ST72.VraSR two-component regulatory system contributes to mprF-mediated decreased susceptibility to daptomycin in in vivo-selected clinical strains of methicillin-resistant Staphylococcus aureus.Staphylococcus epidermidis ΔSortase A strain elicits protective immunity against Staphylococcus aureus infection.Hemoculture and Direct Sputum Detection of mecA-Mediated Methicillin-Resistant Staphylococcus aureus by Loop-Mediated Isothermal Amplification in Combination With a Lateral-Flow Dipstick.Ceftaroline is active against heteroresistant methicillin-resistant Staphylococcus aureus clinical strains despite associated mutational mechanisms and intermediate levels of resistance.Staphylococcus aureus VRSA-11B is a constitutive vancomycin-resistant mutant of vancomycin-dependent VRSA-11A.Fate of mutation rate depends on agr locus expression during oxacillin-mediated heterogeneous-homogeneous selection in methicillin-resistant Staphylococcus aureus clinical strains.
P2860
Q27677278-D6EDC426-ACD3-43D0-AFC1-0D3E1DDCD670Q28486717-ABDCF76C-6E7D-4567-B4B0-9BBBE411FF5EQ28535076-112424B7-01FC-4B7A-8412-68C364DB1A63Q28539724-3AE7D126-CB2B-4D86-8BF3-AC15E82F1E9DQ33716153-D5CE21B2-0033-4201-BDFF-F6AD7ED4F56DQ33798560-42F61BA9-B4AD-49FD-9778-5773FC7FD0E3Q34596507-DB9BCE06-4A65-42D7-8ECD-4382C9799EB2Q34747322-580DAB46-0966-4085-A82B-0B5147535B26Q34885110-517E931F-F37F-4832-860D-FFD8D162E2A0Q35006037-222E68E7-9F3A-4C62-B9A8-307FB4BA6E26Q35944300-9F160A9F-B269-46BB-8023-0A234CF402D0Q36396117-410B7BF6-BE1B-49F5-A300-2D1FF4FCED47Q36538634-AB737FC3-5640-4744-8B23-6235D1E94159Q37291437-5B79775A-25E1-467F-B28B-5730B9C04C54Q37713222-DC8F274E-4BC3-4B5A-9CF3-2E1BBFC9E3FEQ38232037-75B05888-7E16-4BA4-B34C-A198AAC05EE0Q38308807-3AE3E40C-B899-45AD-A09C-279296F05FCDQ38728885-EF2BCA1E-C886-42A1-B1DA-E35A4A18624AQ38736105-2974B0C0-ADFF-4D9D-A607-3147D9F58512Q40327375-2A7178FF-79F2-4059-9ED4-4C09C9CA307FQ40498900-6B3072C7-A488-4329-9089-4F9196A184F6Q40750245-175DE026-B08B-42A1-903A-128EF114FD12Q42206236-2D315D1A-7BE6-42B6-912C-C83D942FDB11Q42281255-4C91277A-6C71-4023-8FCD-477C2DECED7BQ42697562-F809CD61-B5A8-4EF1-A01A-3DD30D5A22EF
P2860
Conversion of oxacillin-resistant staphylococci from heterotypic to homotypic resistance expression.
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
2002年论文
@zh
2002年论文
@zh-cn
name
Conversion of oxacillin-resist ...... motypic resistance expression.
@en
Conversion of oxacillin-resist ...... motypic resistance expression.
@nl
type
label
Conversion of oxacillin-resist ...... motypic resistance expression.
@en
Conversion of oxacillin-resist ...... motypic resistance expression.
@nl
prefLabel
Conversion of oxacillin-resist ...... motypic resistance expression.
@en
Conversion of oxacillin-resist ...... motypic resistance expression.
@nl
P2093
P2860
P1476
Conversion of oxacillin-resist ...... motypic resistance expression.
@en
P2093
A E Rosato
Gordon L Archer
T M Dickinson
P2860
P356
10.1128/AAC.46.1.24-30.2002
P407
P577
2002-01-01T00:00:00Z